Search results

4G Clinical is a global leader in randomisation and trial supply management and supply forecasting optimisation software for the life sciences industry, offering a fully cloud-based, 100% configurable solution using natural language processing to accelerate clinical trials.

Abbmira Therapeutics is a Basel-based biotech founded by experienced scientists and entrepreneurs in September 2024. Abbmira develops first-in-class small molecules to fine-tune native immunity to treat difficult-to-treat cancers and chronic diseases.

ACM Biosciences AG is a subsidiary of ACM Biolabs PTE Ltd. Singapore. Its purpose is to internationalise its development activities. It leads all clinical and regulatory activities of its pipeline programs and coordinates business development discussions with potential partners.

Akceso Advisors: specialist advisory firm focused on pricing, reimbursement and market access. For your buy/sell side 'Evidence-based Asset Valuation' and payer-relevant input into your development plan design. Akceso Advisors: Catalysts to patient access and pricing success. For better public health worldwid

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Amphilix AG is a Basel-based biotech developing next-generation radioligand therapies using a proprietary 3D linker platform and small-molecule ligands. Its clinical-stage lead AMX-0053 targets a protein for colorectal cancer and is ready for First-in-Human imaging. The company seeks CHF 9m Seed.

Amporin is developing a new class of small molecule amyloid pore inhibitors as the first potential acute oral drugs to stop and reverse the progression of deadly degenerative diseases. Our vision is to cure 6 major degenerative diseases with a simple pill, starting with Parkinson’s disease.

AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues. AMYRA’s products have the potential to establish the standard of care and majorly impact the lives of affected people.

Anaveon is a global clinical stage biopharmaceutical company that specializes in developing novel treatments for diseases with high unmet needs. Our team is driven to make this vision a reality: we are committed to transforming immunological insights into life-changing therapies.

AND Biotech is a science-led company developing bioactive technologies that target the core systems of human resilience. We take promising compounds and translate them into clinically meaningful interventions. We develop scalable technologies that address biological decline, starting long before disease.

ANSEA is a global consulting firm enabling pharmaceuticals, biopharmaceuticals and medical device companies navigate through the complexities of healthcare systems across the world and helping bring their solutions to patients.

ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.

Artidis® is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. Artidis focuses its efforts on solid tumors to enhance responses to chemo, immuno, and cell therapies, driving precision in cancer care.

Aukera builds a discovery engine that allows designing new classes of drugs to selectively target different branches of the mTOR pathway. The lead program selectively targets mTOR complex 1 to treat rare diseases, cancer, and neurodegenerative diseases, and uniquely addresses unmet medical needs.

AVEctivate supports pharma, biotech and diagnostic companies aiming to make a positive difference to patients, and health care providers by offering strategic consulting, project management and interim management. Believing that change is the only constant, we embrace the future as an opportunity.

Azafaros is a clinical-stage biotech company addressing rare genetic lysosomal storage disorders with oral small molecules, including nizubaglustat. Our focus is on developing disease-modifying therapies for patients with, among others, GM1 and GM2 gangliosidoses, and Niemann-Pick Type C disease.

Basel Biotech Consutling GmbH provides biotechs and mid-stage pharmas with support on financing and business development. The expertise is based on over 20 years experience in investments having worked as a pharma analyst, fund manager, investor relations and business development professional.

BeOne Medicines is a global oncology company developing innovative, affordable, and accessible cancer treatments worldwide. We expedite development of our diverse pipeline of novel therapeutics through strong internal capabilities and collaborations. Our 11,000 colleagues span six continents.

Management consultancy dedicated to equipping life sciences organizations with clarity and foresight in strategy, execution, and innovation - we blend deep commercial industry expertise and scientific acumen with tools and frameworks from the behavioral sciences, design and systems thinking.

Immune response on a chip!

BiomedVC is a leading Swiss early-stage venture capital fund at the center of European biotech. We focus on finding great science and building promising startups to deliver better medicines for patients.

We are experts in obtaining funding for biomedical and healthcare innovations, as well as for ICT, eHealth and big data fields projects. We help leading researchers and companies secure financing for ambitious R&D projects, from early stage pre-clinical research up to clinical stage development.

Celonic is a “Pure Play” Biologics CDMO with a focus on CHO-based expression systems. Celonic is a pioneer in using next generation bioprocessing technologies and has a state-of-the-art Biologics Development Center in Switzerland, with clinical and commercial GMP manufacturing facilities in Germany.

Cerdia, headquartered in Basel, is a pioneer in cellulose acetate tow since 1912 and a global quality and innovation leader of filter tow for cigarette manufacture. We are developing innovative applications and processes that will define Cellulose Acetate as a sustainable raw material in the future.

CRB is a leading design, construction and consulting firm serving life sciences companies globally since 1984. From small studies to execution of complex projects, we have the expertise to deliver solutions to our clients in the local pharmaceutical and biotechnology market.

CTC – The Life Science Career Network - We provide excellence in Life Science recruitment and the latest in skill development programmes. We enable careers in the Life Science industry and support our clients in engaging, retaining and developing the right talent at the time needed.

Curare specializes in translational and clinical pharmacology, increasing confidence in therapeutics translation from the bench to clinical proof‑of‑concept, and enhancing early stage decision-making. Expertise tailored to your needs, from small biotech to pharma.

EsoCap AG is developing a unique targeted delivery platform technology for the treatment of patients with diseases of the esophagus. EsoCap recently successfully completed the double-blind, randomised, placebo-controlled Phase II ACESO study in the lead indication eosinophilic esophagitis (EoE).

GenH is a global pharma consulting firm supporting CEOs and Boards across Big Pharma and mid-sized companies. We focus on CEO & Board strategy, asset strategy and execution, and transformation and growth to help leaders make better decisions and drive sustainable impact.

FatiAbGen International is the Swiss subsidiary of FatiAbGen Inc., established in Korea in 2020. We engineer best in class antibodies tailored for multiple modalities such as ADCs and bi-specifics. We then develop targeted molecules to address high unmet need diseases in oncology and immunology.

FimmCyte is developing disease modifying therapies for chronic diseases through the direct elimination of diseased cells. FimmCyte has a pipeline of assets two of which are about to begin IND enabling studies, one for endometriosis and the second for organ fibrosis.

At FloBiotech, we develop advanced human brain cell models to unlock new therapeutic and diagnostic pathways for neurodegenerative diseases. We address neurodegeneration at its core to enable earlier risk reduction in drug development, improved translational success, and scalable pipeline expansion.

Biotech venture builder (VC)

FoRx Therapeutics is a clinical-stage company that develops next-generation small molecule therapeutics targeting DNA Replication Stress pathways for anti-cancer therapy. The lead program is a highly potent and selective PARG inhibitor, FORX-428, which  moved into clinical Phase 1 in H2 2025.

GANDA offers tailored G&A services to Life Sciences companies, providing fractional expertise in financial management and planning, human capital, and corporate finance, among others. Their deep industry experience ensures seamless integration without lengthy onboarding.

Genedata transforms biopharma data into intelligence by combining deep science, technology, and AI domain knowledge. From early discovery to the clinic, the Genedata Biopharma Platform digitalizes and automates complex data workflows, driving innovation and data-based decisions to maximize ROI.

Genevant brings world-class delivery platforms that include best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology, the industry’s most robust and expansive LNP patent estate, decades of experience and expertise in nucleic acid drug development.

GenSearch is a global Human Resources services consultancy dedicated to the Life Sciences industries. Our many years' experience allows us to support companies in their different stages of growth - from small start-up's to large multinational players. Offices: Basel, Frankfurt, London, and Paris.

Biotech in the Autoimmune/Fibrosis Therapeutics Space.

Swiss-based Life Sciences consultancy and part of the athagoras Group. We enable European market access for pharma & biotech, combining strategy, evidence generation and HTA expertise, from valuation and trial design to reimbursement, JSC, JCA and pricing negotiations.

HGF GmbH is a leading European intellectual property firm with a dynamic, forward-thinking growth strategy. Located in the heart of Switzerland’s innovation ecosystem, HGF’s Basel office is well positioned to support clients in highly regulated, research-intensive industries.

We offer a integrated service model in the special areas of corporate transactions, international and local accounting & reporting as well as tax, from start-up to IPO or sale. We focus on M&A and CFO services including interim management.

Humans-in the Loop GmbH is an AI-native consultancy built for growing businesses navigating AI adoption. HITL was conceived from the ground up with AI-augmented delivery, an agentic operating team, and a compliance-first posture aligned to the EU AI Act and ISO 42001.

ICON is a global provider of outsourced drug development services and offers a flexible partnership model for biotechs, acting as a fully externalised project development team. We offer a full range of clinical, consulting and commercial services.

Inventicia GmbH/LLC is a consulting firm based in Switzerland, partnering with leading global consulting firms offering innovative solutions across IT, data and digital services to Swiss and European biopharma clients. We also support local representation of international biopharma companies, in particular fr

Jacobs is a world leading consulting, design and construction firm. In Switzerland we have a strong focus on life science industries mainly serving pharmaceutical and biotechnology companies.

Our foundation supports the transfer of innovation from medical research to industry, in particular through young entrepreneurship in Switzerland. We invest in companies in Switzerland and abroad that are active in the field of life sciences. We value strong founding teams and high-quality science.

Kellerhals Carrard's highly specialized and interdisciplinary Life Sciences team is one of the strongest in Switzerland. We advise biotech and pharma clients of all sizes from startups to large multinationals on their most prominent and complex matters, both in Switzerland and abroad.

KVALITO is a strategic service partner and a global Life Science network for regulated industries, focusing on quality We empower businesses in the life science and healthcare industries with ATI, ML, AI, AR / VR, blockchain, big Data, cloud and robotics.

Landmark BioVentures AG, founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company. LBV takes a unique model focused on lean operations, smart capital allocation, and diversified nexus of 8 companies developing 12 first-in-class therapeutics.

At Lederer & Partner AG, we transform complex visions into clear successful results. Our expertise in engineering, construction, commissioning, qualification, and operation, we develop project models that are precisely aligned with your goals. As your trusted partner, we deliver lean, efficient solutions.

Livinovea accelerates biotech, pharma, startups & CDMOs by aligning strategy, science and operations. We build growth-ready operations, reduce cost inefficiencies, resolve challenges accross development and manufacturing. Outside perspective. Inside execution. Measurable results.

Luminance Health is a premium life science consultancy providing personalized support across the entire value chain. We provide cross-functional strategic and hands-on support to develop, register, market and bring innovative products to market.

Macrogen Europe GmbH, Swiss branch of Macrogen Europe B.V. (Amsterdam), provides fast, reliable Sanger and NGS sequencing. All sequencing labs are based in Amsterdam and Seoul. We support research and clinical needs across Europe and Africa with advanced genomic and bioinformatics services.

Maxia Strategies specializes in supporting biotechs with regulatory affairs and project development expertise. We also support in registration and market access activities in the US, EU and Switzerland. We submit MAA act as a MAH, and support in distribution and licensing request in Switzerland.

metaLead is an early-stage life science spinout from the University of Zurich, supported by reputable investors, i.e., BaseLaunch. We aim to revolutionize the treatment landscape for metal-related diseases, starting with Wilson disease, leveraging our platform of novel, rationally designed peptides.

Mosanna is committed to improving patient outcomes and quality of life in high unmet need diseases, carefully selecting innovative medicines for further development. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients.

NBE-Therapeutics engages in the development of “next-generation”, antibody drug conjugates (ADCs) with the objective to develop first-in-class ADC product candidates until clinical proof-of-concept in patients. NBE Therapeutics is part of the Boehringer-Ingelheim group.

NegotiumBio supports pharmaceutical & biotech companies in executing outsourced manufacturing and also business development strategies across diverse modalities (small / large molecules, cell & gene therapies).

Noema Pharma is a clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions.

Nouscom is a privately held oncology company developing next-generation immunotherapies. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

Novaremed AG, a privately held clinical-stage biopharmaceutical company, is innovating chronic pain management through the development of effective and safe treatment options as an alternative to opioids. HQ Basel (Switzerland); subsidiaries Novaremed Ltd (Israel) & Metys Pharmaceuticals (CH).

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Nxera Pharma is a tech-driven biopharma company focused on specialty medicines for unmet needs in Japan and globally. With 30+ active programs in neurology, GI, immunology, metabolic, and rare diseases, Nxera employs 350+ people across Japan, the UK, Switzerland, and South Korea.

NXI Therapeutics is committed to creating tomorrow’s disruptive immunotherapies for T cell-mediated autoimmune diseases and transplantation by coronin 1 modulation. NXI’s unique approach enables an auto- & allo-selective immunomodulation that retains immunocompetence against infections and cancer.

OMNI Life Science GmbH is located in Basel, Switzerland. We are your local partner for solutions in cell-based assays and are dedicated to provide innovative solutions for research in life science.

Pall Biotech offers a blend of innovative traditional, single-use and continuous processing technologies and services to create scalable bioprocessing solutions. From concept through to design, validation and production, Pall leverages best-in class technologies for all bioprocessing applications. Pall (Schwe